Kristie L. Kahl
Breakthroughs in immunotherapy continue to advance in the treatment landscape for cancer, but patients do not always understand what these therapies are and how they work.
This year, the Cancer Research Institute (CRI) is hosting five Immunotherapy Patient Summits for patients, caregivers, and advocates to meet, and for them to learn valuable information from health care experts to learn more about how new breakthroughs in immunotherapy are changing standards of care for all cancers.
In this week’s episode of CURE
Talks Cancer, we spoke with a patient who underwent CAR-T cell therapy in a clinical trial, as well as CRI’s CEO, who offered more information about what these summits consist of and why they’re so helpful.
To learn more, visit: